{
    "nctId": "NCT00247650",
    "briefTitle": "Comparison Study of Letrozole Alone or Letrozole With Zoledronic Acid in Early Breast Cancer, Neoadjuvant Therapy",
    "officialTitle": "Randomized Multi-Center Study Comparing Prolonged Primary Systemic Endocrine Therapy With Letrozole Alone or in Combination With Zoledronic Acid in Early Breast Cancer (NEOadjuvant Study in CANada)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 190,
    "primaryOutcomeMeasure": "Clinical response at 24 weeks",
    "eligibilityCriteria": "Inclusion Criteria\n\n* Postmenopausal women\n* Newly diagnosed with non metastatic breast cancer\n* Candidate for mastectomy or breast-conserving surgery\n\nExclusion Criteria\n\n* Patients with invasive tumors\n* Patients receiving anti-cancer treatment\n* Patients who have undergone surgery\n\nOther protocol-defined exclusion criteria may apply.",
    "sex": "FEMALE",
    "minimumAge": "65 Years",
    "stdAges": "OLDER_ADULT"
}